In conclusion we find the MDM2 SNP del1518 del variant to be associated with reduced risk of endometrial cancer among individuals carrying the SNP309TT genotype, an observation warranting confirmation in independent studies. This evidence concerns the gene MDM2 and endometrial cancer.